This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Acorn Cardiovascular (develops medical devices for heart failure) raised $20mm in a private placement of Series E preferred stock. Johnson & Johnson Development Corp. led the financing and was joined by return investors New Enterprise Associates, CSFB, Piper Jaffray Ventures, Three Arch Partners, Bessemer Venture Partners, Spray Venture Fund, and others.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?